Professional Documents
Culture Documents
International Journal of Dermatology 2000, 39, 126–133 © 2000 Blackwell Science Ltd
Magro and Crowson Lichenoid and granulomatous dermatitis Report 127
Clinical summary
© 2000 Blackwell Science Ltd International Journal of Dermatology 2000, 39, 126–133
128 Report Lichenoid and granulomatous dermatitis Magro and Crowson
46/M Lichenoid dermatitis Extremities/scalp/trunk CMV, retinitis/nasal herpes in the setting of HIV
34/M Zosteriform plaque Back Herpes zoster
5/F Zosteriform eruption Arm Herpes
39/F Linear eruption Leg Hepatitis C
22/F Zosteriform eruption Leg Herpes in the setting of acute myelogenous leukemia
6/F Pityriasis lichenoides Generalized Recurrent streptococcal tonsillitis
61/F Erythematous papules Axilla Infectious mononucleosis
51/M Guttate psoriasis Generalized Recurrent streptococcal tonsillitis
39/F Majocchi’s granuloma vs. GA Arm Mycobacterium marinum
17/M Tinea capitis Scalp Tinea capitis
36/F Secondary syphilis Generalized Serologically proven secondary syphilis
62/M Tuberculoid leprosy Leg Tuberculoid leprosy
Age/sex Clinical impression Location of lesions Underlying medical illnesses Implicated drug
LCV, leucocytoclastic vasculitis; LE, lupus erythematosus; NLD, necrobiosis lipoidica diabeticorum.
CTCL, cutaneous T-cell lymphoma; NLD, necrobiosis lipoidica diabeticorum; PBC, primary biliary cirrhosis.
with the commencement of a drug and/or lesional resolution tors, lipid-lowering agents, β-blockers, H2 antagonists,
following drug withdrawal. The implicated drugs included nonsteroidal anti-inflammatory drugs (NSAIDs), hydroxy-
antibiotics, angiotensin-converting enzyme (ACE) inhibi- chloroquine, and quinine-containing tonic water. In two
International Journal of Dermatology 2000, 39, 126–133 © 2000 Blackwell Science Ltd
Magro and Crowson Lichenoid and granulomatous dermatitis Report 129
Histopathology
© 2000 Blackwell Science Ltd International Journal of Dermatology 2000, 39, 126–133
130 Report Lichenoid and granulomatous dermatitis Magro and Crowson
International Journal of Dermatology 2000, 39, 126–133 © 2000 Blackwell Science Ltd
Magro and Crowson Lichenoid and granulomatous dermatitis Report 131
Discussion
© 2000 Blackwell Science Ltd International Journal of Dermatology 2000, 39, 126–133
132 Report Lichenoid and granulomatous dermatitis Magro and Crowson
therapy in a patient with underlying systemic lupus eryth- infiltrates may manifest in lesions of CTCL as interstitial
ematosus was reported, whereby lymphoid atypia produced infiltrates reminiscent of GA to which the appellations
a morphology reminiscent of granulomatous CTCL;13 ACE granulomatous mycosis fungoides and granulomatous slack
inhibitors are implicated in pseudolymphomatous CTCL- skin are applied.30,31
like infiltrates.14 One patient with RA developed a lichenoid pigmentary
Lichenoid and granulomatous infiltrates are a manifesta- purpura-like reaction with granulomatous vasculitis con-
tion of infection, including active infection, or an idiopathic fined to dermal papillae capillaries. This and a similar
response to nonviable microbial antigen. The organisms reported case32 beg the question as to whether granulomat-
include those with superantigen properties, namely viruses, ous lichenoid pigmentary purpura should be considered a
mycobacterial and treponemal species, and streptococci. manifestation of RA. Most RA patients, however, ingest
Superantigens are microbial proteins which interact with NSAIDs which provoke lichenoid eruptions;12 despite an
the variable region of the T-cell receptor and the conserved absent temporal association between the eruption and drug
residues of class II antigen-presenting cells, thereby stimu- intake, one might view these as lichenoid drug reactions
lating a much larger percentage of the T-cell repertoire with granulomatous koebnerization.
than do traditional bacterial oligopeptides.15–22 Excessive
T-helper 1 (Th1) activity would be expected to generate an Acknowledgments
infiltrate rich in lymphocytes and histiocytes, such as was
seen in these cases.22 Follicular inflammation, lymphocytic Karen Dueck made invaluable secretarial contributions and
eccrine hidradenitis, and perineural infiltrates are also Sharon Allentuch provided library assistance. Lorraine
characteristic, particularly in post-herpetic lesions. Acral Kapitoler assisted in the darkroom, funding for which was
lichenoid and granulomatous purpuric dermatitis in the derived from the Misercordia Foundation, Winnipeg,
setting of antecedent infection with Mycobacterium sp. and Canada.
hepatitis C has been reported.23
Besides the patient with a drug reaction in the setting of References
hepatitis C, cases of hepatobiliary disease included a second
1 Altman J, Perry HO. The variation and course of lichen
patient with hepatitis C and an LS-like eruption clinically,
planus. Arch Dermatol 1961; 84: 179–191.
a patient with variegate porphyria, and one with PBC. 2 Ellis FA. Histopathology of lichen planus based on
Both LP-like eruptions and sarcoidal granulomata have analysis of one hundred biopsy specimens. J Invest
been described in the setting of hepatitis C and PBC,24 but Dermatol 1967; 48: 143–148.
not with variegate porphyria, although the latter is often 3 Almeyda J, Levantine A. Drug reactions XVI. Lichenoid
associated with underlying hepatitis C.25 As regards the drug eruptions. Br J Dermatol 1971; 85: 604–607.
lymphocytic eccrine hidradenitis and granulomatous 4 Jeerapaet P, Ackerman AB. Histologic patterns of
vasculopathy seen in the hepatobiliary disease cases, both secondary syphilis. Arch Dermatol 1973; 107: 373–377.
hepatitis C and PBC demonstrate a T-cell-mediated immun- 5 Magro CM, Crowson AN, Regauer S. Mixed connective
ologic response directed at bile duct epithelium. Antigenic tissue disease. A clinical, histologic, and
immunofluorescence study of eight cases. Am
homology between basilar epidermis and bile duct
J Dermatopathol 1997; 19: 205–212.
epithelia could result in a concomitant lymphocytic and
6 Magro CM, Crowson AN, Harrist TJ. The use of
granulomatous phenomenon affecting both structures.25 antibody to C5b-9 in the subclassification of lupus
The eccrine involvement in our cases mirrors the changes erythematosus. Br J Dermatol 1996; 134: 855–862.
seen in the portal tracts in PBC and hepatitis C;26,27 patients 7 Magro CM, Regaeur S, Crowson AN. Granuloma
with PBC also develop lymphocytic infiltrates in their annulare and necrobiosis lipoidica tissue reactions in
lacrimal and salivary glands.28 A common immunologic association with systemic disease. Hum Pathol 1996;
injury mechanism may exist for all epithelial duct structures 27: 50–56.
in these patients, reflecting antigenic similarity between bile 8 Ellis FA, Hill WF. Is lichen nitidus a variety of lichen
duct and eccrine epithelia, as both express cytokeratin 18.29 planus: Arch Dermatol Syph 1938; 38: 569–573.
A superficial band-like infiltrate of atypical lymphocytes 9 Lee H. Lichen striatus. Lancet 1951; 1: 615–617.
10 Staricco RG. Lichen striatus. A study of 15 new cases
and granulomata with variable epitheliotropism was
with special emphasis on the histopathological changes
characteristic of patients with CTCL. Clinically, the erup-
and review of the literature. Arch Dermatol 1959; 79:
tions were consistent with CTCL; none was described as 311–324.
‘‘lichenoid.’’ Absent epidermal injury (except for one case 11 Senea FE, Caro MA. Lichen striatus. Arch Dermatol
where there was prior PUVA therapy), a sclerotic papillary Syph 1941; 43: 116–133.
dermis, and haphazard epidermal permeation by cerebri- 12 Crowson AN, Magro CM. Drug eruptions. In: Barnhill
form lymphocytes were helpful clues.14 Granulomatous R, Crowson AN, Busam K, Granter S, eds. Textbook of
International Journal of Dermatology 2000, 39, 126–133 © 2000 Blackwell Science Ltd
Magro and Crowson Lichenoid and granulomatous dermatitis Report 133
© 2000 Blackwell Science Ltd International Journal of Dermatology 2000, 39, 126–133